Exact Mass: 349.2042

Exact Mass Matches: 349.2042

Found 378 metabolites which its exact mass value is equals to given mass value 349.2042, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cetiedil

3-Thiopheneacetic acid, alpha-cyclohexyl-, 2-(hexahydro-1H-azepin-1-yl)ethyl ester, hydrochloride (1:1)

C20H31NO2S (349.2075)


C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D006401 - Hematologic Agents > D000986 - Antisickling Agents ATC code: C04AX26

   

Fenpropathrin

2,2,3,3-Tetramethylcyclopropanecarboxylic acid cyano(3-phenoxyphenyl)methyl ester

C22H23NO3 (349.1678)


D010575 - Pesticides > D007306 - Insecticides > D011722 - Pyrethrins

   

AMD-070

(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

C21H27N5 (349.2266)


C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist > C107589 - CXCR4 Inhibitor

   

Murrayazolinine

2-{13,16-dimethyl-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaen-19-yl}propan-2-ol

C23H27NO2 (349.2042)


Murrayazolinine is found in herbs and spices. Murrayazolinine is an alkaloid from the stem bark of Murraya koenigii (curryleaf tree

   

Demethoxyfumitremorgin C

12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4(9),5,7-tetraene-14,20-dione

C21H23N3O2 (349.179)


Demethoxyfumitremorgin C is produced by Aspergillus fumigatu

   

Mahanimbinine

5-{3,5-dimethyl-3H,11H-pyrano[3,2-a]carbazol-3-yl}-2-methylpentan-2-ol

C23H27NO2 (349.2042)


Mahanimbinine is found in herbs and spices. Mahanimbinine is an alkaloid from leaves of Murraya koenigii (curryleaf tree

   

Coutaric acid

4-[(2R)-2-(Aminomethyl)-2-(hydroxymethyl)-5-oxopyrrolidin-1-YL]-3-[(1-ethylpropyl)amino]benzoic acid

C18H27N3O4 (349.2001)


Coutaric acid is a fecal metabolite from grape juice. It may also be in urine. It is an ester formed from coumaric acid and tartaric acid.

   

(3R,4S)-2-[6-(Cyclohexylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

(3R,4S)-2-[6-(Cyclohexylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O4 (349.175)


   

(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

C21H27N5 (349.2266)


   

Abeado

5-(((Z)-4-Amino-2-butenyl)methylamino)-5-deoxyadenosine

C15H23N7O3 (349.1862)


   

Abiraterone

2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-7,13-dien-5-ol

C24H31NO (349.2406)


   

N-Hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-2-propenamide

N-Hydroxy3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enimidate

C21H23N3O2 (349.179)


   

Cyclohexyladenosine

2-(6-amino-9H-purin-9-yl)-2-cyclohexyl-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O4 (349.175)


   

Dipipanone

4,4-diphenyl-6-(piperidin-1-yl)heptan-3-one

C24H31NO (349.2406)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

Dansylamidohexamethylamine

N-(6-aminohexyl)-5-(dimethylamino)naphthalene-1-sulfonamide

C18H27N3O2S (349.1824)


   

Pancopride

4-Amino-N-{1-azabicyclo[2.2.2]octan-3-yl}-5-chloro-2-(cyclopropylmethoxy)benzene-1-carboximidate

C18H24ClN3O2 (349.1557)


   

Vernakalant

1-[2-[2-(3,4-Dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol

C20H31NO4 (349.2253)


   

Sodium dodecylbenzenesulfonate

Sodium 3-dodecylbenzene-1-sulphonic acid

C18H30NaO3S (349.1813)


Surfactant for use in washing or lye peeling of fruit and vegetables and in poultry scald solutions

   

Arachin

2-methoxy-6-[(2E)-4-(2-methylpiperidin-1-yl)-1,2-dihydroquinazolin-2-ylidene]cyclohexa-2,4-dien-1-one

C21H23N3O2 (349.179)


Arachin is a member of the class of compounds known as quinazolinamines. Quinazolinamines are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups. Arachin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Arachin can be found in peanut, which makes arachin a potential biomarker for the consumption of this food product. Kodashim or Kodshim or Qodhashim (Hebrew: קדשים‎ "Holy Things") is the fifth Order in the Mishnah (also the Tosefta and Talmud). Of the six Orders of the Mishnah, it is the third longest. Kodoshim deals largely with the religious service within the Temple in Jerusalem, the qorbanot ("sacrificial offerings"), and other subjects considered or related to these "Holy Things" .

   

(5Z)-(15S)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate

(5Z)-7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-[(1E)-3-oxooct-1-en-1-yl]cyclopentyl]hept-5-enoate

C20H29O5 (349.2015)


(5z)-(15s)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate, also known as 15-dehydro-prostaglandin e2 anion, is a member of the class of compounds known as prostaglandins and related compounds. Prostaglandins and related compounds are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid (5z)-(15s)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (5z)-(15s)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate can be found in a number of food items such as maitake, green zucchini, yellow pond-lily, and canada blueberry, which makes (5z)-(15s)-11-alpha-hydroxy-9,15-dioxoprosta-13-enoate a potential biomarker for the consumption of these food products. (5z)-(15s)-11-α-hydroxy-9,15-dioxoprosta-13-enoate, also known as 15-dehydro-prostaglandin e2 anion, is a member of the class of compounds known as prostaglandins and related compounds. Prostaglandins and related compounds are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid (5z)-(15s)-11-α-hydroxy-9,15-dioxoprosta-13-enoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (5z)-(15s)-11-α-hydroxy-9,15-dioxoprosta-13-enoate can be found in a number of food items such as maitake, green zucchini, yellow pond-lily, and canada blueberry, which makes (5z)-(15s)-11-α-hydroxy-9,15-dioxoprosta-13-enoate a potential biomarker for the consumption of these food products.

   

16, 17-dihydro-16alpha, 17-dihydroxy GA9

(2R,5R,6R,8R,9S,10R,11S)-6-hydroxy-6-(hydroxymethyl)-11-methyl-16-oxo-15-oxapentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadecane-9-carboxylate

C19H25O6- (349.1651)


16, 17-dihydro-16alpha, 17-dihydroxy ga9 is also known as 16α, 17-[oh]2 gibberellin a9. 16, 17-dihydro-16alpha, 17-dihydroxy ga9 is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 16, 17-dihydro-16alpha, 17-dihydroxy ga9 can be found in a number of food items such as spirulina, leek, tinda, and fenugreek, which makes 16, 17-dihydro-16alpha, 17-dihydroxy ga9 a potential biomarker for the consumption of these food products. 16, 17-dihydro-16α, 17-dihydroxy ga9 is also known as 16α, 17-[oh]2 gibberellin a9. 16, 17-dihydro-16α, 17-dihydroxy ga9 is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 16, 17-dihydro-16α, 17-dihydroxy ga9 can be found in a number of food items such as spirulina, leek, tinda, and fenugreek, which makes 16, 17-dihydro-16α, 17-dihydroxy ga9 a potential biomarker for the consumption of these food products.

   

12,13-Dihydroprolyl-2-(1,1-dimethylallyltryptophyl) diketopiperazine

12,13-Dihydroprolyl-2-(1,1-dimethylallyltryptophyl) diketopiperazine

C21H23N3O2 (349.179)


   

Preparaherquamide

Preparaherquamide

C22H27N3O (349.2154)


   

Acetyllycoclavine

Acetyllycoclavine

C20H31NO4 (349.2253)


   

Murrayamine O

Murrayamine O

C23H27NO2 (349.2042)


   
   
   

Acetylfawcettiine

beta-Lofoline acetate

C20H31NO4 (349.2253)


   
   
   
   
   
   
   

5-Fluoro AMB metabolite 7

5-Fluoro AMB metabolite 7

C18H24FN3O3 (349.1802)


   
   
   

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-benzyl-1h-indole-3-carboxamide

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-benzyl-1h-indole-3-carboxamide

C21H23N3O2 (349.179)


   
   
   

CHEMBL3431128

CHEMBL3431128

C19H23N7 (349.2015)


   
   

3-[2-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-1,2,3,4,6,7-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

3-[2-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-1,2,3,4,6,7-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

C21H23N3O2 (349.179)


   

19-(alpha-Methyl)-18-deoxy-15,22-dihydro-3-iso-cadamin|5-methyl-3,5,7,8,13,13b,14,14a-octahydro-indolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridine-1-carboxylic acid methyl ester

19-(alpha-Methyl)-18-deoxy-15,22-dihydro-3-iso-cadamin|5-methyl-3,5,7,8,13,13b,14,14a-octahydro-indolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridine-1-carboxylic acid methyl ester

C21H23N3O2 (349.179)


   

tricalysiamide D

tricalysiamide D

C20H31NO4 (349.2253)


   

(-)-alancine|alancine

(-)-alancine|alancine

C19H27NO5 (349.1889)


   

Mahanimbinine

5-{5,8-dimethyl-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaen-5-yl}-2-methylpentan-2-ol

C23H27NO2 (349.2042)


   

SCHEMBL4904241

SCHEMBL4904241

C23H27NO2 (349.2042)


   
   
   

Tyloindicine E

Tyloindicine E

C22H23NO3 (349.1678)


   

2-(2-amino-beta-D-2-deoxy-gulopyranosylamino)-5-(2-amino-1-hydroxy-ethyl)-4,5-dihydro-1H-imidazole-4-carboxylic acid

2-(2-amino-beta-D-2-deoxy-gulopyranosylamino)-5-(2-amino-1-hydroxy-ethyl)-4,5-dihydro-1H-imidazole-4-carboxylic acid

C12H23N5O7 (349.1597)


   

Murrayazolinine

2-{13,16-dimethyl-15-oxa-4-azapentacyclo[14.3.1.0^{2,14}.0^{3,11}.0^{5,10}]icosa-2,5,7,9,11,13-hexaen-19-yl}propan-2-ol

C23H27NO2 (349.2042)


   
   

brevianamide V

brevianamide V

C21H23N3O2 (349.179)


   

deoxydihydroisoaustamide

deoxydihydroisoaustamide

C21H23N3O2 (349.179)


   

prealmazole C

prealmazole C

C21H23N3O2 (349.179)


   

Reutericyclin

Reutericyclin

C20H31NO4 (349.2253)


   

(-)-lepadin C|(2S,3S,4aS,5S,8aR)-2-methyl-5-[(1E,3E)-7-oxo-1,3-octadienyl]decahydro-3-quinolinyl hydroxyacetate|lepadin C

(-)-lepadin C|(2S,3S,4aS,5S,8aR)-2-methyl-5-[(1E,3E)-7-oxo-1,3-octadienyl]decahydro-3-quinolinyl hydroxyacetate|lepadin C

C20H31NO4 (349.2253)


   

2-[6-(1,3-Benzodioxole-5-yl)hexyl]-4(1H)-quinolinone

2-[6-(1,3-Benzodioxole-5-yl)hexyl]-4(1H)-quinolinone

C22H23NO3 (349.1678)


   

4-dihydroconsabatine

4-dihydroconsabatine

C20H31NO4 (349.2253)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Abiraterone

Abiraterone (CB-7598)

C24H31NO (349.2406)


A 3beta-sterol that is androsta-5,16-dien-3beta-ol substituted at position 17 by a 3-pyridyl group. Administered as the O-acetate, it is used for treatment of metastatic castrate-resistant prostate cancer. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen C471 - Enzyme Inhibitor > C147923 - CYP17A1 Inhibitor

   
   
   
   

12,13-dehydroprolyl-2-(1,1-dimethylallyltryptophyl)diketopiperazine

12,13-dehydroprolyl-2-(1,1-dimethylallyltryptophyl)diketopiperazine

C21H23N3O2 (349.179)


   

3,N4-Epoxyoctenal-deoxycytidine

3,N4-Epoxyoctenal-deoxycytidine

C17H23N3O5 (349.1638)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

dipipanone

dipipanone

C24H31NO (349.2406)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   
   

MDA-19

(2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide, benzoic acid

C21H23N3O2 (349.179)


   

JWH018 adamantyl

1-pentyl-3-(1-adamantoyl)indole

C24H31NO (349.2406)


   

Coutaric acid

4-[(2R)-2-(aminomethyl)-2-(hydroxymethyl)-5-oxopyrrolidin-1-yl]-3-[(pentan-3-yl)amino]benzoic acid

C18H27N3O4 (349.2001)


   

Demethoxyfumitremorgin C

12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0^{3,11}.0^{4,9}.0^{15,19}]icosa-3(11),4,6,8-tetraene-14,20-dione

C21H23N3O2 (349.179)


An organic heteropentacyclic compound that is a mycotoxic indole alkaloid, consisting of fumitremorgin C lacking the 9-methoxy substituent.

   

SDBS Surfactant

sodium 4-dodecylbenzene-1-sulfonic acid

C18H30NaO3S (349.1813)


   

L-Alanine, N-(1-carboxyethyl)- (9CI)

L-Alanine, N-(1-carboxyethyl)- (9CI)

C17H32ClNO4 (349.202)


   

3-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]-1H-indol-2-one

3-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]-1H-indol-2-one

C23H27NO2 (349.2042)


   

N,N-Dimethyl-N-octyl-1-octanaminium bromide

N,N-Dimethyl-N-octyl-1-octanaminium bromide

C18H40BrN (349.2344)


   

5-(2,6-DIFLUOROPHENYL)TETRAZOLE

5-(2,6-DIFLUOROPHENYL)TETRAZOLE

C18H27NO4Si (349.1709)


   

Vernakalant

Vernakalant

C20H31NO4 (349.2253)


C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent C93038 - Cation Channel Blocker

   

2-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL) PYRIDINE-4-BORONIC ACID PINACOL ESTER

2-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL) PYRIDINE-4-BORONIC ACID PINACOL ESTER

C18H32BNO3Si (349.2244)


   

1-Benzyl 4-tert-butyl 2-(aminomethyl) piperazine-1,4-dicarboxylate

1-Benzyl 4-tert-butyl 2-(aminomethyl) piperazine-1,4-dicarboxylate

C18H27N3O4 (349.2001)


   

azepan-2-one,butane-1,4-diol,hexanedioic acid

azepan-2-one,butane-1,4-diol,hexanedioic acid

C16H31NO7 (349.21)


   

5-(Bis(2-hydroxyethyl)amino)-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester

5-(Bis(2-hydroxyethyl)amino)-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester

C18H27N3O4 (349.2001)


   

n-(3-acryloxy-2-hydroxypropyl)-3-aminopropyltriethoxysilane

n-(3-acryloxy-2-hydroxypropyl)-3-aminopropyltriethoxysilane

C15H31NO6Si (349.1921)


   

METHYL 3-CYCLOHEXYL-2-(2-HYDROXYPHENYL)-1H-INDOLE-6-CARBOXYLATE

METHYL 3-CYCLOHEXYL-2-(2-HYDROXYPHENYL)-1H-INDOLE-6-CARBOXYLATE

C22H23NO3 (349.1678)


   

Trifluralin D14 (di-n-propyl D14)

Trifluralin D14 (di-n-propyl D14)

C13H2D14F3N3O4 (349.1972)


   

(R )-5-(2-aminopropyl)-1-(3-benzyloxypropyl) indoline-7-carbonitrile

(R )-5-(2-aminopropyl)-1-(3-benzyloxypropyl) indoline-7-carbonitrile

C22H27N3O (349.2154)


   

3-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

3-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

C18H32BNO3Si (349.2244)


   

2-Nitrophenyl myristate

2-Nitrophenyl myristate

C20H31NO4 (349.2253)


   

2-AMINO-1-BENZYL-4,5-DIPHENYL-1H-PYRROLE-3-CARBONITRILE

2-AMINO-1-BENZYL-4,5-DIPHENYL-1H-PYRROLE-3-CARBONITRILE

C24H19N3 (349.1579)


   

Aluminum magnesium isopropoxide

Aluminum magnesium isopropoxide

C15H38AlMgO5 (349.2385)


   

TERT-BUTYL (S)-4-(CBZ-AMINO)-5-METHYL-3-OXOHEXANOATE

TERT-BUTYL (S)-4-(CBZ-AMINO)-5-METHYL-3-OXOHEXANOATE

C19H27NO5 (349.1889)


   
   

1-[(TERT-BUTYL)OXYCARBONYL]-3-(4-METHOXYBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

1-[(TERT-BUTYL)OXYCARBONYL]-3-(4-METHOXYBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

C19H27NO5 (349.1889)


   

1-[Decanoyl(methyl)amino]-1-deoxy-D-glucitol

1-[Decanoyl(methyl)amino]-1-deoxy-D-glucitol

C17H35NO6 (349.2464)


   

2-Methyl-2-propanyl (11-bromoundecyl)carbamate

2-Methyl-2-propanyl (11-bromoundecyl)carbamate

C16H32BrNO2 (349.1616)


   

TERT-BUTYL (2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)CARBAMATE

TERT-BUTYL (2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)CARBAMATE

C18H28BNO5 (349.206)


   

2-CYCLOHEXYL-1-OXO-3-PHENYL-1,2,3,4-TETRAHYDRO-4-ISOQUINOLINECARBOXYLIC ACID

2-CYCLOHEXYL-1-OXO-3-PHENYL-1,2,3,4-TETRAHYDRO-4-ISOQUINOLINECARBOXYLIC ACID

C22H23NO3 (349.1678)


   

6-([(tert-Butyldimethylsilyl)oxy]methyl)pyridine-3-boronic acid pinacol ester

6-([(tert-Butyldimethylsilyl)oxy]methyl)pyridine-3-boronic acid pinacol ester

C18H32BNO3Si (349.2244)


   

sodium lauroamphoacetate

sodium lauroamphoacetate

C18H34N2NaO3 (349.2467)


   

1-METHYL-N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)-1H-BENZO[D]IMIDAZOL-2-AMINE

1-METHYL-N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)-1H-BENZO[D]IMIDAZOL-2-AMINE

C20H24BN3O2 (349.1961)


   

Panobinostat

Panobinostat

C21H23N3O2 (349.179)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XH - Histone deacetylase (hdac) inhibitors D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents

   

TRIS(4-METHOXYPHENYL)BORANE-AMMONIA COMPLEX

TRIS(4-METHOXYPHENYL)BORANE-AMMONIA COMPLEX

C21H24BNO3 (349.1849)


   

Tetradecyldimethylethylammonium bromide

Tetradecyldimethylethylammonium bromide

C18H40BrN (349.2344)


   

N-Cyclopentyl-2-C-methyladenosine

N-Cyclopentyl-2-C-methyladenosine

C16H23N5O4 (349.175)


   

4-Nitrophenyl myristate

4-Nitrophenyl myristate

C20H31NO4 (349.2253)


   

2-piperidin-1-ylethyl 2,2-diphenylcyclopropane-1-carboxylate

2-piperidin-1-ylethyl 2,2-diphenylcyclopropane-1-carboxylate

C23H27NO2 (349.2042)


   

R-1-N-Cbz-4-N-Boc-2-aminomethylpiparazine

R-1-N-Cbz-4-N-Boc-2-aminomethylpiparazine

C18H27N3O4 (349.2001)


   

1-tert-butyl 2-Methyl 2-(2-(benzylaMino)ethyl)azetidine-1,2-dicarboxylate

1-tert-butyl 2-Methyl 2-(2-(benzylaMino)ethyl)azetidine-1,2-dicarboxylate

C19H29N2O4 (349.2127)


   
   

MENTHOLGLUCURONIC ACID AMMONIUM SALT

MENTHOLGLUCURONIC ACID AMMONIUM SALT

C16H31NO7 (349.21)


   
   

N6-Cyclohexyladenosine

N6-Cyclohexyladenosine

C16H23N5O4 (349.175)


N6-Cyclohexyladenosine is a selective adenosine A1 receptor agonist (EC50 = 8.2 nM). N6-Cyclohexyladenosine is a selective adenosine A1 receptor agonist (EC50 = 8.2 nM).

   

Methylamino-phenylalanyl-leucyl-hydroxamic acid

Methylamino-phenylalanyl-leucyl-hydroxamic acid

C18H27N3O4 (349.2001)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors

   

1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Phenylurea

1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Phenylurea

C20H23N5O (349.1903)


   
   

N-(1H-benzimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

N-(1H-benzimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

C21H27N5 (349.2266)


   

PAPP

PAPP

C19H22F3N3 (349.1766)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists LY 165163 is a potent 5-HT presynaptic receptor agonist. LY 165163 significantly decreases 5-HTP accumulation and increases DOPA accumulation in the cortex and striatum[1].

   

1-Azabicyclo[2.2.2]octan-3-yl-bis(3,4-dimethylphenyl)methanol

1-Azabicyclo[2.2.2]octan-3-yl-bis(3,4-dimethylphenyl)methanol

C24H31NO (349.2406)


   

Oxayohimbanium, 3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19-methyl-, (19alpha,20alpha)-

Oxayohimbanium, 3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19-methyl-, (19alpha,20alpha)-

C21H21N2O3+ (349.1552)


   

2-(cyclohexylamino)-N-[(diphenylmethylene)amino]propanamide

2-(cyclohexylamino)-N-[(diphenylmethylene)amino]propanamide

C22H27N3O (349.2154)


   
   

L-Seryl-L-prolyl-L-phenylalanine

L-Seryl-L-prolyl-L-phenylalanine

C17H23N3O5 (349.1638)


   

L-Prolyl-L-seryl-L-phenylalanine

L-Prolyl-L-seryl-L-phenylalanine

C17H23N3O5 (349.1638)


   

cis-4-Methyl-N-[(1S)-3-(methylsulfanyl)-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide

cis-4-Methyl-N-[(1S)-3-(methylsulfanyl)-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide

C18H27N3O2S (349.1824)


   

2-[2-[(2-Amino-3-phenylpropanoyl)amino]propanoylamino]-4-methylpentanoic acid

2-[2-[(2-Amino-3-phenylpropanoyl)amino]propanoylamino]-4-methylpentanoic acid

C18H27N3O4 (349.2001)


   
   
   

resolvin E1(1-)

resolvin E1(1-)

C20H29O5- (349.2015)


An icosanoid anion resulting from the removal of a proton from the carboxy group of resolvin E1; major species at pH 7.3.

   

5(S)-hydroperoxy-18(R)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoate

5(S)-hydroperoxy-18(R)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoate

C20H29O5- (349.2015)


An icosanoid anion arising from deprotonation of the carboxylic acid function of 5(S)-hydroperoxy-18(R)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoic acid; major species at pH 7.3.

   

15-dehydro-prostaglandin E2(1-)

15-dehydro-prostaglandin E2(1-)

C20H29O5- (349.2015)


Conjugate base of 15-dehydro-prostaglandin E2.

   

15-dehydro-prostaglandin I2(1-)

15-dehydro-prostaglandin I2(1-)

C20H29O5- (349.2015)


Conjugate base of 15-dehydro-prostaglandin I2.

   

15-dehydro-prostaglandin D2(1-)

15-dehydro-prostaglandin D2(1-)

C20H29O5- (349.2015)


Conjugate base of 15-dehydro-prostaglandin D2.

   

16alpha, 17-[OH]2 gibberellin A9

16alpha, 17-[OH]2 gibberellin A9

C19H25O6- (349.1651)


   

(6E)-2-methoxy-6-[4-(2-methylpiperidin-1-yl)-1H-quinazolin-2-ylidene]cyclohexa-2,4-dien-1-one

(6E)-2-methoxy-6-[4-(2-methylpiperidin-1-yl)-1H-quinazolin-2-ylidene]cyclohexa-2,4-dien-1-one

C21H23N3O2 (349.179)


   

2-[[[(E)-4-aminobut-2-enyl]-methylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol

2-[[[(E)-4-aminobut-2-enyl]-methylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol

C15H23N7O3 (349.1862)


   

Sodium;3-dodecylbenzenesulfonic acid

Sodium;3-dodecylbenzenesulfonic acid

C18H30NaO3S+ (349.1813)


   
   

Cathestatin A

Cathestatin A

C17H23N3O5 (349.1638)


A dicarboxylic acid monoamide obtained by the formal condensation of the carboxylic group of oxirane-2,3-dicarboxylic acid with the amino group of N-(4-aminobutyl)-L-phenylalaninamide (the 2S,3S stereoisomer). An antibiotic isolated from the fermentation broth of Penicillium citrinum, it acts as a potent inhibitor of cysteine protease.

   

Pyrrolo(1,2-a)pyrazine-1,4-dione, 3-((2-(1,1-dimethyl-2-propenyl)-1H-indol-3-yl)methyl)-2,3,6,7-tetrahydro-, (S)-

Pyrrolo(1,2-a)pyrazine-1,4-dione, 3-((2-(1,1-dimethyl-2-propenyl)-1H-indol-3-yl)methyl)-2,3,6,7-tetrahydro-, (S)-

C21H23N3O2 (349.179)


   

(5S)-hydroperoxy-18-hydroxy-EPE(1-)

(5S)-hydroperoxy-18-hydroxy-EPE(1-)

C20H29O5- (349.2015)


An icosanoid anion that is the conjugate base of (5S)-hydroperoxy-18-hydroxy-EPE, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

(5S,6Z,8E,10E,12R,14Z,16E,18S)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate

(5S,6Z,8E,10E,12R,14Z,16E,18S)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate

C20H29O5- (349.2015)


   
   
   
   

N-ethyl-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-N-(phenylmethyl)propanamide

N-ethyl-3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-N-(phenylmethyl)propanamide

C21H23N3O2 (349.179)


   

prostaglandin D3(1-)

prostaglandin D3(1-)

C20H29O5- (349.2015)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin D3, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

15-oxolipoxin A4(1-)

15-oxolipoxin A4(1-)

C20H29O5- (349.2015)


A hydroxy fatty acid anion obtained by deprotonation of the carboxy function of 15-oxolipoxin A4; major species at pH 7.3.

   

20-oxoleukotriene B4(1-)

20-oxoleukotriene B4(1-)

C20H29O5- (349.2015)


A leukotriene anion that is the conjugate base of 20-oxoleukotriene B4 arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

N-(4-tert-butylphenyl)-2-[4-(1-imidazolyl)phenoxy]acetamide

N-(4-tert-butylphenyl)-2-[4-(1-imidazolyl)phenoxy]acetamide

C21H23N3O2 (349.179)


   

1-[1-Methyl-2-(1-pyrrolidinylmethyl)-5-benzimidazolyl]-3-phenylurea

1-[1-Methyl-2-(1-pyrrolidinylmethyl)-5-benzimidazolyl]-3-phenylurea

C20H23N5O (349.1903)


   

1-[4-(4-hydroxyphenyl)-1-piperazinyl]-3-(1H-indol-3-yl)-1-propanone

1-[4-(4-hydroxyphenyl)-1-piperazinyl]-3-(1H-indol-3-yl)-1-propanone

C21H23N3O2 (349.179)


   

1-(2-methylphenyl)-3-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)thiourea

1-(2-methylphenyl)-3-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)thiourea

C21H23N3S (349.1613)


   

(5S)-hydroperoxy-(18S)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoate

(5S)-hydroperoxy-(18S)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoate

C20H29O5- (349.2015)


An icosanoid anion that is the conjugate base of (5S)-hydroperoxy-(18S)-hydroxy-(6E,8Z,11Z,14Z,16E)-icosapentaenoic acid, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.

   

N-[(2-hydroxy-1-naphthalenyl)-(4-methoxyphenyl)methyl]-2-methylpropanamide

N-[(2-hydroxy-1-naphthalenyl)-(4-methoxyphenyl)methyl]-2-methylpropanamide

C22H23NO3 (349.1678)


   

carbocyclic thromboxane A2(1-)

carbocyclic thromboxane A2(1-)

C21H33O4- (349.2379)


   

N-(4-Oxo-3,4-dihydro-quinazolin-2-ylmethyl)-N-phenethyl-butyramide

N-(4-Oxo-3,4-dihydro-quinazolin-2-ylmethyl)-N-phenethyl-butyramide

C21H23N3O2 (349.179)


   

(5Z,13E,15S,17Z)-11alpha,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oate

(5Z,13E,15S,17Z)-11alpha,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oate

C20H29O5- (349.2015)


   

(5Z,9S,11R,13E,15S,17Z)-15-Hydroxy-9,11-epidioxyprosta-5,13,17-trienoate

(5Z,9S,11R,13E,15S,17Z)-15-Hydroxy-9,11-epidioxyprosta-5,13,17-trienoate

C20H29O5- (349.2015)


   

N1-cyclohexyl-4-(4-fluorobenzyl)-1,4-diazepane-1-carbothioamide

N1-cyclohexyl-4-(4-fluorobenzyl)-1,4-diazepane-1-carbothioamide

C19H28FN3S (349.1988)


   

2-[(1-Methyl-2-benzimidazolyl)amino]-5-spiro[1,6,7,8-tetrahydroquinazoline-4,1-cyclopentane]one

2-[(1-Methyl-2-benzimidazolyl)amino]-5-spiro[1,6,7,8-tetrahydroquinazoline-4,1-cyclopentane]one

C20H23N5O (349.1903)


   

(5S,6Z,8E,10E,14Z)-5,20-dihydroxy-12-oxoicosa-6,8,10,14-tetraenoate

(5S,6Z,8E,10E,14Z)-5,20-dihydroxy-12-oxoicosa-6,8,10,14-tetraenoate

C20H29O5- (349.2015)


   

(7E,9E,11Z,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoate

(7E,9E,11Z,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoate

C20H29O5- (349.2015)


   

(6Z,8E,10E,14Z,16E,18R)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate

(6Z,8E,10E,14Z,16E,18R)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoate

C20H29O5- (349.2015)


   
   
   
   
   

(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoic acid

(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoic acid

C18H27N3O4 (349.2001)


   
   
   
   
   
   
   
   
   
   
   
   

(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

2-(dimethylamino)-1-[(1S,5R)-7-[4-(3-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone

2-(dimethylamino)-1-[(1S,5R)-7-[4-(3-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone

C22H27N3O (349.2154)


   

2-[(3R,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3R,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3R,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3R,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3S,6aR,8R,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3S,6aR,8R,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3S,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3S,6aS,8S,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(1S,5R)-7-[4-(2-methylphenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

(1S,5R)-7-[4-(2-methylphenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

C22H27N3O (349.2154)


   

(1R,5S)-7-[4-(4-methylphenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

(1R,5S)-7-[4-(4-methylphenyl)phenyl]-N-propyl-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C22H27N3O (349.2154)


   

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-10-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-10-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

2-[(3R,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3R,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3S,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3S,6aS,8R,10aS)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   

2-[(3S,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

2-[(3S,6aR,8S,10aR)-3-hydroxy-1,2,3,4,6,6a,8,9,10,10a-decahydropyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyridin-4-ylethyl)acetamide

C18H27N3O4 (349.2001)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(5E)-2-(diethylamino)-5-[(4-methoxyphenyl)methylidene]-3-phenylimidazol-4-one

(5E)-2-(diethylamino)-5-[(4-methoxyphenyl)methylidene]-3-phenylimidazol-4-one

C21H23N3O2 (349.179)


   

2-N-methyl-2-N-[(1R)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethyl]pyrimido[4,5-d]pyrimidine-2,5,7-triamine

2-N-methyl-2-N-[(1R)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethyl]pyrimido[4,5-d]pyrimidine-2,5,7-triamine

C19H23N7 (349.2015)


   

(3S,8R,9R,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol

(3S,8R,9R,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol

C24H31NO (349.2406)


   

N-Acetylglycylphenylalanylalanine methyl ester

N-Acetylglycylphenylalanylalanine methyl ester

C17H23N3O5 (349.1638)


   

N-Acetylalanylphenylalanylglycine methyl ester

N-Acetylalanylphenylalanylglycine methyl ester

C17H23N3O5 (349.1638)


   

N-Acetyl-alanyl-phenylalanyl-glycine methylester

N-Acetyl-alanyl-phenylalanyl-glycine methylester

C17H23N3O5 (349.1638)


   

1-[Diethyl(phenylethynyl)silyl]-2-(diethylsilyl)benzene

1-[Diethyl(phenylethynyl)silyl]-2-(diethylsilyl)benzene

C22H29Si2 (349.1808)


   

Fenpropathrin

fenpropathrin [ANSI]

C22H23NO3 (349.1678)


D010575 - Pesticides > D007306 - Insecticides > D011722 - Pyrethrins

   

Cetiedil

2-(azepan-1-yl)ethyl 2-cyclohexyl-2-thiophen-3-ylacetate

C20H31NO2S (349.2075)


C - Cardiovascular system > C04 - Peripheral vasodilators > C04A - Peripheral vasodilators C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D006401 - Hematologic Agents > D000986 - Antisickling Agents ATC code: C04AX26

   

2-[6-(Cyclohexylamino)-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

2-[6-(Cyclohexylamino)-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O4 (349.175)


   

prostaglandin E3(1-)

prostaglandin E3(1-)

C20H29O5 (349.2015)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin E3, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

prostaglandin H3(1-)

prostaglandin H3(1-)

C20H29O5 (349.2015)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin H3, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(18S)-resolvin E1(1-)

(18S)-resolvin E1(1-)

C20H29O5 (349.2015)


An icosanoid anion that is the conjugate base of (18S)-resolvin E1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

alstonine(1+)

alstonine(1+)

C21H21N2O3 (349.1552)


An organic cation resulting from the protonation of the carbonilide moiety of alstonine. The major microspecies at pH 7.3.

   

serpentine(1+)

serpentine(1+)

C21H21N2O3 (349.1552)


An organic cation that is the conjugate acid of serpentine. It is the major species at pH 7.3.

   

NA-Taurine 15:0

NA-Taurine 15:0

C17H35NO4S (349.2287)


   
   
   
   
   

ST 18:1;O2;Gly

ST 18:1;O2;Gly

C20H31NO4 (349.2253)


   

ML289

ML289

C22H23NO3 (349.1678)


ML289 (VU0463597) is a potent, selective, and CNS-penetrant mGlu3 (IC50=0.66 μM) negative allosteric modulator. ML289 displays >15-fold selectivity over mGlu2 and is inactive against mGlu5[1]. ML289 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

Reutericyclin

Reutericyclin

C20H31NO4 (349.2253)


Reutericyclin (Reutericycline), a unique tetramic acid, is an antibiotic produced by some strains of Lactobacillus reuteri. Reutericyclin (Reutericycline) exhibits a broad inhibitory spectrum including Lactobacillus spp., Bacillus subtilis, B. cereus, Enterococcus faecalis, Staphylococcus aureus, and Listeria innocua[1][2].

   

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-methyl-9h-carbazole-2,7-diol

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-methyl-9h-carbazole-2,7-diol

C23H27NO2 (349.2042)


   

1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C21H23N3O2 (349.179)


   

11-hydroxy-4,8,12-trimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

11-hydroxy-4,8,12-trimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

C20H31NO2S (349.2075)


   

(1s,13s,15r,16r)-12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15r,16r)-12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C22H27N3O (349.2154)


   

12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C22H27N3O (349.2154)


   

(2e)-3-phenyl-n-(4-{[(2e)-3-phenylprop-2-enoyl]oxy}butyl)prop-2-enimidic acid

(2e)-3-phenyl-n-(4-{[(2e)-3-phenylprop-2-enoyl]oxy}butyl)prop-2-enimidic acid

C22H23NO3 (349.1678)


   

(3s)-1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3h,6h,7h-pyrrolo[1,2-a]pyrazin-4-one

(3s)-1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3h,6h,7h-pyrrolo[1,2-a]pyrazin-4-one

C21H23N3O2 (349.179)


   

(3z,8as)-1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

(3z,8as)-1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C21H23N3O2 (349.179)


   

(8e)-9-{[(2s)-1-hydroxy-3-(2-hydroxyphenyl)propan-2-yl]-c-hydroxycarbonimidoyl}non-8-enoic acid

(8e)-9-{[(2s)-1-hydroxy-3-(2-hydroxyphenyl)propan-2-yl]-c-hydroxycarbonimidoyl}non-8-enoic acid

C19H27NO5 (349.1889)


   

17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

C20H31NO4 (349.2253)


   

5-hydroxy-4-(5-hydroxyhex-2-en-1-yl)-4-(2-methyl-6-oxooxan-4-yl)-2-(propan-2-ylidene)pyrrol-3-one

5-hydroxy-4-(5-hydroxyhex-2-en-1-yl)-4-(2-methyl-6-oxooxan-4-yl)-2-(propan-2-ylidene)pyrrol-3-one

C19H27NO5 (349.1889)


   

(20r)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

(20r)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

C22H23NO3 (349.1678)


   

(1r,2r,10s,11s,12s,13r,15r)-11-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-12-yl acetate

(1r,2r,10s,11s,12s,13r,15r)-11-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-12-yl acetate

C20H31NO4 (349.2253)


   

(5S,6S,15R)-15-Methyllycopodane-5,6-diol 5,6-diacetate

NA

C20H31NO4 (349.2253)


{"Ingredient_id": "HBIN011943","Ingredient_name": "(5S,6S,15R)-15-Methyllycopodane-5,6-diol 5,6-diacetate","Alias": "NA","Ingredient_formula": "C20H31NO4","Ingredient_Smile": "CC1CC2C3CCCN4C3(C1)C(CCC4)C(C2OC(=O)C)OC(=O)C","Ingredient_weight": "349.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "459","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21576176","DrugBank_id": "NA"}

   

acetylfawcettiine

NA

C20H31NO4 (349.2253)


{"Ingredient_id": "HBIN014474","Ingredient_name": "acetylfawcettiine","Alias": "NA","Ingredient_formula": "C20H31NO4","Ingredient_Smile": "CC1CC23C4CCCN2CCCC3C(CC4C1OC(=O)C)OC(=O)C","Ingredient_weight": "349.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38577","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101500246","DrugBank_id": "NA"}

   

n-{5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl}dec-2-enimidic acid

n-{5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl}dec-2-enimidic acid

C19H27NO5 (349.1889)


   

(20r)-4,5-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

(20r)-4,5-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

C22H23NO3 (349.1678)


   

2-({2-[(4-carbamimidamido-1-carboxy-3-hydroxybutyl)amino]ethyl}amino)butanedioic acid

2-({2-[(4-carbamimidamido-1-carboxy-3-hydroxybutyl)amino]ethyl}amino)butanedioic acid

C12H23N5O7 (349.1597)


   

5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

C22H23NO3 (349.1678)


   

(2s,4ar,13cr)-2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

(2s,4ar,13cr)-2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

C23H27NO2 (349.2042)


   

1-(3,7-dimethylocta-2,6-dien-1-yl)-3-methyl-9h-carbazole-2,7-diol

1-(3,7-dimethylocta-2,6-dien-1-yl)-3-methyl-9h-carbazole-2,7-diol

C23H27NO2 (349.2042)


   

n-{4-hydroxy-2-[(undecyloxy)carbonyl]phenyl}ethanimidic acid

n-{4-hydroxy-2-[(undecyloxy)carbonyl]phenyl}ethanimidic acid

C20H31NO4 (349.2253)


   

(1r,2r,10s,11r,13s,14r,15s)-14-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

(1r,2r,10s,11r,13s,14r,15s)-14-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C20H31NO4 (349.2253)


   

(1s,13s,15s,17r)-12,12,17-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15s,17r)-12,12,17-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C22H27N3O (349.2154)


   

n-{2-hydroxy-5-[(undecyloxy)carbonyl]phenyl}ethanimidic acid

n-{2-hydroxy-5-[(undecyloxy)carbonyl]phenyl}ethanimidic acid

C20H31NO4 (349.2253)


   

3-({1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

3-({1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

C17H23N3O5 (349.1638)


   

3-phenyl-n-{4-[(3-phenylprop-2-enoyl)oxy]butyl}prop-2-enimidic acid

3-phenyl-n-{4-[(3-phenylprop-2-enoyl)oxy]butyl}prop-2-enimidic acid

C22H23NO3 (349.1678)


   

(1s,2r,10r,11r,13r,14s,15r)-11-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-14-yl acetate

(1s,2r,10r,11r,13r,14s,15r)-11-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-14-yl acetate

C20H31NO4 (349.2253)


   

12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C21H23N3O2 (349.179)


   

(2r)-2-[(2-{[(1s,3r)-4-carbamimidamido-1-carboxy-3-hydroxybutyl]amino}ethyl)amino]butanedioic acid

(2r)-2-[(2-{[(1s,3r)-4-carbamimidamido-1-carboxy-3-hydroxybutyl]amino}ethyl)amino]butanedioic acid

C12H23N5O7 (349.1597)


   

2-[6-(2h-1,3-benzodioxol-5-yl)hexyl]-1h-quinolin-4-one

2-[6-(2h-1,3-benzodioxol-5-yl)hexyl]-1h-quinolin-4-one

C22H23NO3 (349.1678)


   

2-methyl-5-(7-oxoocta-1,3-dien-1-yl)-decahydroquinolin-3-yl 2-hydroxyacetate

2-methyl-5-(7-oxoocta-1,3-dien-1-yl)-decahydroquinolin-3-yl 2-hydroxyacetate

C20H31NO4 (349.2253)


   

2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

C23H27NO2 (349.2042)


   

(1r,13r,15s,16s)-12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1r,13r,15s,16s)-12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C22H27N3O (349.2154)


   

(4s,8z,11s,12e)-11-hydroxy-4,8,12-trimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

(4s,8z,11s,12e)-11-hydroxy-4,8,12-trimethyl-13-(2-methyl-1,3-thiazol-4-yl)trideca-8,12-dien-3-one

C20H31NO2S (349.2075)


   

(4r)-5-hydroxy-4-[(2e)-5-hydroxyhex-2-en-1-yl]-4-[(2r,4r)-2-methyl-6-oxooxan-4-yl]-2-(propan-2-ylidene)pyrrol-3-one

(4r)-5-hydroxy-4-[(2e)-5-hydroxyhex-2-en-1-yl]-4-[(2r,4r)-2-methyl-6-oxooxan-4-yl]-2-(propan-2-ylidene)pyrrol-3-one

C19H27NO5 (349.1889)


   

(1s,13s,15r,16s)-12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

(1s,13s,15r,16s)-12,12,16-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C22H27N3O (349.2154)


   

(2s)-1-{[(3r,3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-9-methylidene-decahydronaphtho[1,2-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid

(2s)-1-{[(3r,3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-9-methylidene-decahydronaphtho[1,2-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid

C20H31NO4 (349.2253)


   

5,6-dihydroxy-7-isopropyl-5,6-dimethyl-4-methylidene-3-oxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-1(15)-en-8-one

5,6-dihydroxy-7-isopropyl-5,6-dimethyl-4-methylidene-3-oxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-1(15)-en-8-one

C20H31NO4 (349.2253)


   

1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3h,6h,7h-pyrrolo[1,2-a]pyrazin-4-one

1-hydroxy-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-3h,6h,7h-pyrrolo[1,2-a]pyrazin-4-one

C21H23N3O2 (349.179)


   

(20s)-4,5-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

(20s)-4,5-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

C22H23NO3 (349.1678)


   

12-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

12-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C20H31NO4 (349.2253)


   

(4s)-5-hydroxy-4-[(2e)-5-hydroxyhex-2-en-1-yl]-4-[(2r,4s)-2-methyl-6-oxooxan-4-yl]-2-(propan-2-ylidene)pyrrol-3-one

(4s)-5-hydroxy-4-[(2e)-5-hydroxyhex-2-en-1-yl]-4-[(2r,4s)-2-methyl-6-oxooxan-4-yl]-2-(propan-2-ylidene)pyrrol-3-one

C19H27NO5 (349.1889)


   

{3-ethyl-8-hydroxy-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}acetic acid

{3-ethyl-8-hydroxy-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}acetic acid

C19H27NO5 (349.1889)


   

(4s)-5-hydroxy-4-[(2z)-5-hydroxyhex-2-en-1-yl]-4-[(2r,4s)-2-methyl-6-oxooxan-4-yl]-2-(propan-2-ylidene)pyrrol-3-one

(4s)-5-hydroxy-4-[(2z)-5-hydroxyhex-2-en-1-yl]-4-[(2r,4s)-2-methyl-6-oxooxan-4-yl]-2-(propan-2-ylidene)pyrrol-3-one

C19H27NO5 (349.1889)


   

(1s,4s,5r,9r,12r,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

(1s,4s,5r,9r,12r,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

C20H31NO4 (349.2253)


   

(2r,4ar,13cr)-2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

(2r,4ar,13cr)-2,5,5,7-tetramethyl-1h,3h,4h,4ah,13h,13ch-isochromeno[4,3-a]carbazol-2-ol

C23H27NO2 (349.2042)


   

12,12,17-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

12,12,17-trimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol

C22H27N3O (349.2154)


   

15-hydroxy-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8,18-pentaen-17-one

15-hydroxy-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8,18-pentaen-17-one

C23H27NO2 (349.2042)


   

n-(4-hydroxy-2-{[(9-methyldecyl)oxy]carbonyl}phenyl)ethanimidic acid

n-(4-hydroxy-2-{[(9-methyldecyl)oxy]carbonyl}phenyl)ethanimidic acid

C20H31NO4 (349.2253)


   

4,5-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

4,5-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

C22H23NO3 (349.1678)


   

14-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

14-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C20H31NO4 (349.2253)


   

3-acetyl-1-(dec-2-enoyl)-4-hydroxy-5-(2-methylpropyl)-5h-pyrrol-2-one

3-acetyl-1-(dec-2-enoyl)-4-hydroxy-5-(2-methylpropyl)-5h-pyrrol-2-one

C20H31NO4 (349.2253)


   

(2s,3s,4as,5s,8ar)-2-methyl-5-[(1e,3e)-7-oxoocta-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

(2s,3s,4as,5s,8ar)-2-methyl-5-[(1e,3e)-7-oxoocta-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

C20H31NO4 (349.2253)


   

(13r,16s)-12,12,16-trimethyl-10,19,22-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-21-ol

(13r,16s)-12,12,16-trimethyl-10,19,22-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-21-ol

C22H27N3O (349.2154)


   

1-(3,7-dimethylocta-2,6-dien-1-yl)-6-methyl-9h-carbazole-2,7-diol

1-(3,7-dimethylocta-2,6-dien-1-yl)-6-methyl-9h-carbazole-2,7-diol

C23H27NO2 (349.2042)


   

(2s)-2-(dimethylamino)-n-[2-(1h-indol-3-yl)-2-oxoethyl]-3-phenylpropanimidic acid

(2s)-2-(dimethylamino)-n-[2-(1h-indol-3-yl)-2-oxoethyl]-3-phenylpropanimidic acid

C21H23N3O2 (349.179)


   

(2e)-n-[(1s,2s,4's,5'r,6s)-5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl]dec-2-enimidic acid

(2e)-n-[(1s,2s,4's,5'r,6s)-5'-hydroxy-3-oxo-7-oxaspiro[bicyclo[4.1.0]heptane-2,2'-oxolan]-4-en-4'-yl]dec-2-enimidic acid

C19H27NO5 (349.1889)


   

lecanindole a

lecanindole a

C23H27NO2 (349.2042)


   

[(2r,3r,11bs)-3-ethyl-8-hydroxy-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]acetic acid

[(2r,3r,11bs)-3-ethyl-8-hydroxy-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]acetic acid

C19H27NO5 (349.1889)


   

(2s,3s)-3-{[(1s)-1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

(2s,3s)-3-{[(1s)-1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

C17H23N3O5 (349.1638)


   

(1s,4r,5r,9r,12r,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

(1s,4r,5r,9r,12r,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

C20H31NO4 (349.2253)


   

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-methyl-9h-carbazole-2,7-diol

1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-methyl-9h-carbazole-2,7-diol

C23H27NO2 (349.2042)